Back to News
Market Impact: 0.2
Inspire Wins AMA Approval For New CPT Codes Covering Inspire V System
Source: Nasdaq
Healthcare & BiotechRegulation & LegislationProduct Launches
The CPT Editorial Panel approved new Category I CPT codes specifically covering Inspire V's hypoglossal nerve stimulation system, effective January 1, 2028. The coding designation could support clearer reimbursement and billing for the sleep-apnea treatment system, though the long lead time limits near-term financial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- Mark Ruffalo says Paramount’s $111 billion Warner Bros. deal ‘Will stifle creativity, weaken free speech, and cost people their jobs’
- States, cities sue U.S. agencies over weaker vehicle fuel economy rules
- Anthropic warns government attitudes may hurt customer ties, IPO prospectus shows: Reuters
- Paramount and Warner Bros Discovery to become Skydance
- FAA says Boeing 737 Max software glitch not a flight-safety issue
- Paramount’s Warner Bros. megamerger will just be called Skydance
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI Tools for Family Offices: A Stack by Decision Type
- Reading Conviction in the Tape: What Level 3 Order Book Data Really Tells Discretionary PMs